Endurance Performance: Genes or Gene Combinations?

Abstract

We assessed the possible association between variants of the genes encoding for the angiotensin-converting enzyme (ACE) and α-actinin-3 (ACTN3) (both individually and combined) and several endurance phenotypic traits, e.g., peak power output (PPO), ventilatory (VT) and respiratory compensation threshold (RCT), among others, in professional road cyclists and sedentary controls (n = 46 each). We applied an ANCOVA test using the aforementioned phenotype traits as dependent variables, ACE and/or ACTN3 genotype as the fixed (independent) factor and age and body mass as covariates. We only found a significant genotype effect with no concomitant covariate effect for ACTN3, with cyclists who were not α-actinin-3 deficient (RR + RX genotypes) having higher PPO and VT values than their XX counterparts (mean [SEM]: 7.4 (0.1) vs. 7.1 (0.1) W/kg, p = 0.035; and 4.5 (0.1) vs. 4.3 (0.1) W/kg, p = 0.029, respectively). Cyclists with an “extreme” ACTN3 and ACE genotype combination, i.e., most strength/power oriented (DD + RR/RX), had higher RCT values than those with the “intermediate” combinations (II + RX/RR, p = 0.036; and DD + XX, p = .0004) but similar to those with the most endurance oriented genotype (II + XX). No significant differences (p > 0.05) were found in controls. In summary, in world-class cyclists, we only found an association between ACTN3 genotypes and VT and PPO, and between ACTN3/ACE genotype combinations and RCT.

Key words

ACTN3 - ACE - gross efficiency - delta efficiency - respiratory compensation threshold

References

• 1 Chavarren J, Calbet J AL. Cycling efficiency and pedalling frequency in road cyclists.  Eur J Appl Physiol Occup Physiol. 1999;  80 555-563
• 2 Coyle E F. Improved muscular efficiency displayed as Tour de France champion matures.  J Appl Physiol. 2005;  98 2191-2196
• 3 Coyle E F, Sidossis L S, Horowitz J F, Beltz J D. Cycling efficiency is related to the percentage of type I muscle fibers.  Med Sci Sports Exerc. 1992;  24 782-788
• 4 Crow M T, Kushmerick M J. Chemical energetics of slow- and fast-twitch muscles of the mouse.  J Gen Physiol. 1982;  79 147-166
• 5 Doherty M, Nobbs L, Noakes T D. Low frequency of the “plateau phenomenon” during maximal exercise in elite British athletes.  Eur J Appl Physiol. 2003;  89 619-623
• 6 Foster C, Lucia A. Running economy: the forgotten factor in elite performance.  Sports Med. 2007;  37 316-319
• 7 Howley E T, Bassett J R, Welch H G. Criteria for maximal oxygen uptake: review and commentary.  Med Sci Sports Exerc. 1995;  27 1292-1301
• 8 Jones A, Montgomery H E, Woods D R. Human performance: a role for the ACE genotype?.  Exerc Sport Sci Rev. 2002;  30 184-190
• 9 Jones A, Woods D R. Skeletal muscle RAS and exercise performance.  Int J Biochem Cell Biol. 2003;  35 855-866
• 10 Kuipers H, Verstappen F T, Keizer H A, Geurten P, van Kranenburg G. Variability of aerobic performance in the laboratory and its physiologic correlates.  Int J Sports Med. 1985;  6 197-201
• 11 Lamarra N, Whipp B J, Ward S A, Wasserman K. Effect of interbreath fluctuations on characterizing exercise gas exchange kinetics.  J Appl Physiol. 1987;  62 2003-2012
• 12 Lucia A, Gómez-Gallego F, Chicharro J L, Hoyos J, Celaya K, Córdova A, Villa G, Alonso J M, Barriopedro M, Pérez M, Earnest C P. Is there an association between ACE and CKMM polymorphisms and cycling performance status during 3-week races?.  Int J Sports Med. 2005;  26 442-447
• 13 Lucia A, Gomez-Gallego F, Santiago C, Bandrés F, Earnest C, Rabadán M, Alonso J M, Hoyos J, Córdova A, Villa G, Foster C. ACTN3 genotype in professional endurance cyclists.  Int J Sports Med. 2006;  27 880-884
• 14 Lucia A, Hoyos J, Pérez M, Santalla A, Chicharro J L. Inverse relationship between V˙O_2max and economy/efficiency in world-class cyclists.  Med Sci Sports Exerc. 2002;  34 2079-2084
• 15 Lucia A, Hoyos J, Santalla A, Pérez M, Earnest C, Chicharro J L. Which laboratory variable is related with time trial performance in the Tour de France?.  Br J Sports Med. 2004;  38 636-640
• 16 Lucía A, Rabadán M, Hoyos J, Hernández-Capilla M, Pérez M, San Juan A F, Earnest C P, Chicharro J L. Frequency of the V˙O_2max plateau phenomenon in world-class cyclists.  Int J Sports Med. 2006;  27 984-992
• 17 MacArthur D G, North K N. ACTN3: A genetic influence on muscle function and athletic performance.  Exerc Sport Sci Rev. 2007;  35 30-34
• 18 Meyer T, Lucia A, Earnest C P, Kindermann W. A conceptual framework for performance diagnosis and training prescription from submaximal gas exchange parameters–theory and application.  Int J Sports Med. 2005;  26 (Suppl 1) S38-S48
• 19 Mills M, Tang R, Weinberger R, Vander Woude D L, Beggs A H, Easteal S, North K. Differential expression of the actin-binding proteins, α-actinin-2 and − 3, in different species: implications for the evolution of functional redundancy.  Hum Mol Gen. 2001;  10 1335-1346
• 20 Rankinen T, Bray M S, Hagberg J M, Pérusse L, Roth S M, Wolfarth B, Bouchard C. The human gene map for performance and health-related fitness phenotypes: the 2005 update.  Med Sci Sports Exerc. 2006;  38 1863-1888
• 21 Rankinen T, Wolfarth B, Simoneau J-A, Maier-Lenz D, Rauramaa R, Rivera M A, Boulay M R, Chagnon Y C, Pérusse L, Keul J, Bouchard C. No association between the angiotensin-converting enzyme ID polymorphism and elite endurance athlete status.  J Appl Physiol. 2000;  88 1571-1575
• 22 Rieder M J, Taylor S L, Clark A G, Nickerson D A. Sequence variation in the human angiotensin converting enzyme.  Nat Genet. 1999;  22 59-62
• 23 Pérez M, Lucia A, Santalla A, Chicharro J L. Effects of electrical stimulation on V˙O₂ kinetics and delta efficiency in healthy young men.  Br J Sports Med. 2003;  37 140-143
• 24 Poch E, de La Sierra A, González-Núñez D, Oriola J, Redón J, Chaves F J, Marín P, Giner V, Pamies E, Villar J, Ramírez R, Stiefel P, Rodríguez Pérez J C, Rodríguez Esparragón F, Martínez E, Carrión L, Sanchís C, Divisón J A. Grupo Español de Genética e Hipertensión Arterial de la Sociedad Española de hipertensión/Liga Española para la Lucha contra la Hipertensión Arterial . [Genetic polymorphisms of the renin-angiotensin system and essential hypertension].  Med Clin (Barc). 2002;  118 575-579
• 25 Rietjens G J, Kuipers H, Kester A D, Keizer H A. Validation of a computerized metabolic measurement system (Oxycon-Pro) during low and high intensity exercise.  Int J Sports Med. 2001;  22 291-294
• 26 Saltin B, Larsen H, Terrados N, Bangsbo J, Bak T, Kim C K, Svedenhag J, Rolf C J. Aerobic exercise capacity at sea level and at altitude in Kenyan boys, junior and senior runners compared with Scandinavian runners.  Scand J Med Sci Sports. 1995;  5 209-221
• 27 Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd edn. Cold Springs; Harbour Laboratory Press 1989
• 28 Squire J M. Architecture and function in the muscle sarcomere.  Curr Opin Struct Biol. 1997;  7 247-257
• 29 Van den Eede E, Van Leemputte M, Hespel P J, Thomis M. The ACTN3 (R577X) genotype is associated with fiber type distribution.  Physiol Genomics. 2007;  19 (32) 58-63
• 30 Williams A G, Rayson M P, Jubb M, World M, Woods D R, Hayward M, Martin J, Humphries S E, Montgomery H E. The ACE gene and muscle performance.  Nature. 2000;  403 614
• 31 Yang N, MacArthur D G, Gulbin J P, Hahn A G, Beggs A H, Easteal S, North K. ACTN3 genotype is associated with human elite athletic performance.  Am J Hum Genet. 2003;  73 627-631
• 32 Zhao G, Bernstein R D, Hintze T H. Nitric oxide and oxygen utilization: exercise, heart failure and diabetes.  Coron Artery Dis. 1999;  10 315-320